Circulating tumor cell count and overall survival in patients with metastatic hormone-sensitive prostate cancer
A Goldkorn, C Tangen, M Plets, D Bsteh, T Xu… - JAMA network …, 2024 - jamanetwork.com
Importance In metastatic hormone-sensitive prostate cancer (mHSPC), new first-line
combination therapies have enhanced overall survival (OS), but clinical outcomes for …
combination therapies have enhanced overall survival (OS), but clinical outcomes for …
Utilization of Circulating Tumor Cells in the Management of Solid Tumors
PC Kurniali, MH Storandt, Z Jin - Journal of Personalized Medicine, 2023 - mdpi.com
Circulating tumor cells (CTCs) are tumor cells shed from the primary tumor into circulation,
with clusters of CTCs responsible for cancer metastases. CTC detection and isolation from …
with clusters of CTCs responsible for cancer metastases. CTC detection and isolation from …
Recent advances in blood-based liquid biopsy approaches in prostate cancer
The advent of high-throughput technologies has enabled the analysis of minute amounts of
tumor-derived material purified from body fluids, termed “liquid biopsies.” Prostate cancer …
tumor-derived material purified from body fluids, termed “liquid biopsies.” Prostate cancer …
Highlighting recent progress in the treatment of men with advanced prostate cancer
T Gourdin - Current Opinion in Oncology, 2024 - journals.lww.com
Highlighting recent progress in the treatment of men with ad... : Current Opinion in Oncology
Highlighting recent progress in the treatment of men with advanced prostate cancer …
Highlighting recent progress in the treatment of men with advanced prostate cancer …